One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation

BACKGROUND: Hepatitis B immunoglobulin (HBIG) given in combination with a nucleos(t)ide analogue has reduced the rate of recurrent hepatitis B virus (HBV) infection following liver transplantation (LT); however, the most effective protocol remains unclear. OBJECTIVE: To evaluate the use of tenofovir...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tanaka, Tomohiro, Renner, Eberhard L, Selzner, Nazia, Therapondos, George, Lilly, Leslie B
Format: Artigo
Jezik:Inglês
Izdano: Pulsus Group Inc 2014
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4071906/
https://ncbi.nlm.nih.gov/pubmed/24212911
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki